1887

Abstract

SUMMARY

An athymic rat strain lacking functional T cells was used to assess the role of cell-mediated immunity (CMI) in host defence against renal infection. CMI was ruled out as a relevant host defence component, but when cyclosporin A (CsA) was administered to athymic animals, renal infection was exacerbated. CsA is thought to affect T lymphocyte function and, in the absence of a target cell, cellular defences in the athymic animal were not expected to be compromised by CsA. An effect on non-cellular defence mechanisms was therefore considered but our studies did not support this explanation–rather they indicated a depression of either cellular defences or of a specific cellular component. The present experiments have provided additional information on the relationship between CsA administration and the depression of host defence mechanisms but further studies will be necessary to identify the components affected.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-26-4-245
1988-08-01
2024-06-19
Loading full text...

Full text loading...

/deliver/fulltext/jmm/26/4/medmicro-26-4-245.html?itemId=/content/journal/jmm/10.1099/00222615-26-4-245&mimeType=html&fmt=ahah

References

  1. Bunjes D., Hardt C., Rollinghoff M., Wagner H. 1981; Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2. European Journal of Immunology 11:657–661
    [Google Scholar]
  2. Douglas-Jones A., Nelson J., Jansen V., Miller T. 1981; Characterization of the (rnunz) nude rat. Morphological characteristics of the lymphoid system. Australian Journal of Experimental Biology and Medical Science 59:277–286
    [Google Scholar]
  3. Hess A. D., Colombani P. M., Esa A. H. 1986; Cyclosporine and the immune response: basic aspects. CRC Critical Reviews in Immunology 6:123–149
    [Google Scholar]
  4. Janco R. L., English D. 1983; Cyclosporine and human neutrophil function. Transplantation 35:501–503
    [Google Scholar]
  5. Kahan B. D. 1985; Cyclosporine: the agent and its actions. Transplantation Proceedings 17: Suppl 15–18
    [Google Scholar]
  6. Loliger C., Lehmann-Grube F. 1985; Mechanism of recovery from acute virus infection. II. Effect of treatment of mice with cyclosporin A on their ability to eliminate the lymphocytic choriomeningitis virus. Medical Microbiology and Immunology 174:187–196
    [Google Scholar]
  7. Marshall E., Miller T. 1981; Characterization of the nude rat (rnunz). Functional characteristics. Australian Journal of Experimental Biology and Medical Science 59:287–296
    [Google Scholar]
  8. Miller T. E., Findon G. 1985; Experimental candidosis: paw oedema in the analysis of a local infection. Journal of Medical Microbiology 20:283–290
    [Google Scholar]
  9. Miller T. E., Findon G. 1986; Modulation of host defenses against pyogenic microorganisms by cyclosporine. Transplantation 42:463–466
    [Google Scholar]
  10. Miller T. E., Findon G., Cawley S., Clarke I. 1986; Cellular basis of host defence in pyelonephritis. II. Acute infection. British Journal of Experimental Pathology 67:191–200
    [Google Scholar]
  11. MillerT E., Robinson K. B. 1973; Experimental pyelonephritis: a new method for inducing pyelonephritis in the rat. Journal of Infectious Diseases 127:307–310
    [Google Scholar]
  12. Moffat F. L. 1985; Reversal of cyclosporine-induced mortality with a synthetic polymeric immunostimulant in a murine model of fecal peritonitis. Transplantation 39:369–374
    [Google Scholar]
  13. Murray B. M., Paller M. S., Ferris T. F. 1985; Effect of cyclosporine administration on renal hemodynamics in conscious rats. Kidney International 28:767–774
    [Google Scholar]
  14. Najarian J. S. 1983; Comparison of cyclosporine versus azathioprine-antilymphocyte globulin in renal transplantation. Transplantation Proceedings 15:2463–2468
    [Google Scholar]
  15. Ormrod D. J., Cawley S., Miller T. E. 1985; Extended immunosuppression with cyclophosphamide using controlled-release polymeric implants. International Journal of Immunopharmacology 7:443–448
    [Google Scholar]
  16. Oyer P. E. 1983; Cyclosporine in cardiac transplantation: a 2j year follow-up. Transplantation Proceedings 15:2546–2552
    [Google Scholar]
  17. Perfect J. R., Durack D. T. 1985; Effects of cyclosporine in experimental cryptococcal meningitis. Infection and Immunity 50:22–26
    [Google Scholar]
  18. Schaffner A., Douglas H., Davis C. E. 1983; Models of T cell deficiency in listeriosis: the effects of cortisone and cyclosporin A on normal and nude BALB/c mice. Journal of Immunology 131:450–453
    [Google Scholar]
  19. Sells R. A. 1983; A prospective randomized substitutive trial of cyclosporine as a prophylactic agent in human renal transplant rejection. Transplantation Proceedings 15:2495–2500
    [Google Scholar]
  20. Shiel A. G. R. 1983; Australian trial of cyclosporine (CsA) in cadaveric donor renal transplantation. Transplantation Proceedings 15:2485–2489
    [Google Scholar]
  21. Thomson A. W., Whiting P. H., Cameron I. D., Lessels S. E., Simpson J. G. 1981; A toxicological study in rats receiving immunotherapeutic doses of cyclosporin A. Transplantation 31:121–124
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-26-4-245
Loading
/content/journal/jmm/10.1099/00222615-26-4-245
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error